2017
Jensen IS, Wu E, Sacks N , Cyr P, Chung K. 2017. Budget impact analysis of CPX-351 in the treatment of patients with treatment-related acute myeloid leukemia (tAML) or AML with myelodysplasia-related changes (MRC) from a US payer perspective. Blood 130:5615.
View Abstract
Publication: Manuscripts
Young LY, Sacks NC , Cyr PL, Sharma A, Dahdal DN. 2017. Comparison of claims data on hospitalization rates and repeat procedures in patients receiving a bowel preparation prior to colonoscopy. Sage Open Medicine , August 31.
View Abstract
Publication: Manuscripts
2016
Sacks NC , Cyr P, Liu Y, Miller DJ, Chiarella MT, Louie AC. 2016. Burden of acute myeloid leukemia (AML) among older newly-diagnosed patients. Blood 128(22):4780.
View Abstract
Publication: Manuscripts
Sacks NC , Noone J, Cyr PL, Miller DJ, Chiarella MT, Louie AC. 2016. Hospitalizations for older patients with acute myeloid leukemia (AML): Inpatient treatment is intensive and costly. Value in Health 19(3):A246 [abstract].
View Abstract
Publication: Manuscripts
Sacks NC , Sharma A, Cyr PL, Liu Y, Miller DJ, Chiarella MT, Louie AC. 2016. Outcomes for older patients with acute myeloid leukemia (AML): Multiple hospitalizations and high mortality rates. Value in Health 19(7):A611 [abstract].
View Abstract
Publication: Manuscripts
2015
Sacks NC , Ash AS, Ghosh K, Rosen AK, Wong JB, Cutler DM, Rosen AB. 2015. Recent national trends in acute myocardial infarction hospitalizations in Medicare: Shrinking declines and growing disparities [Letter to the Editor]. Epidemiology 26(4):e46–47.
Publication: Manuscripts
Sacks NC , Burgess JF, Cabral HJ, Pizer SD. 2015. The effects of cost sharing on adherence to medications prescribed for concurrent use: Do definitions matter? J Manag Care Pharmacy , 21(8):678–687.
View Abstract
Publication: Manuscripts
Sacks NC , Ash AS, Ghosh K, Rosen AK, Wong JB, Rosen AB. 2015. Implications of ignoring growing proportions of hospitalizations with acute myocardial infraction. Am Heart J, December 2015.
Publication: Manuscripts
2013
Sacks NC . 2013. Avoidable costs in U.S. healthcare: The $200 billion opportunity from using medicines more responsibly. IMS Health , June.
View Abstract
Publication: Manuscripts
Sacks NC , Burgess JF, Cabral HJ, Pizer SD, McDonnell, ME. 2013. Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries. J Gen Intern Med 28(7):876–885.
View Abstract
A Division of